A Role for Phosphatidylinositol 3-Kinase in Generating T Cell Help for B Cell Growth and Differentiation

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 2769-2778

  Aagaard Tillery, Kjersti M ^a   Jelinek, Diane F ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CD40 LIGAND; CHROMONE DERIVATIVE; ENZYME INHIBITOR; MEMBRANE PROTEIN; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; WORTMANNIN;

ADULT; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGY; LYMPHOCYTE FUNCTION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; ANDROSTADIENES; B-LYMPHOCYTES; CD40 LIGAND; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHROMONES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE COOPERATION; MEMBRANE GLYCOPROTEINS; MORPHOLINES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0030265654     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.157.7.2769     Document Type: Article

References (65)

1. Hirohata, S., D. F. Jelinek, and P. E. Lipsky. 1988. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J. Immunol. 140:3726.
2. Tohma, S., and P. E. Lipsky. 1991. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. J. Immunol. 146:2544.
3. Kehry, M. R., and B. E. Castle. 1994. Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation. Semin. Immunol. 6:287.
4. Splawski, J. B., and P. E. Lipsky. 1994. CD40-mediated regulation of human B-cell responses. Res. Immunol. 145:226.
5. Banchereau, J., F. Bazan, D. Blanchard, R. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
6. Gray, D., K. Siepmann, and G. Wohlleben. 1994. CD40 ligation in B cell activation, isotype switching, and memory development. Semin. Immunol. 6:303.
7. Clark, E. A., and J. A. Ledbetter. 1994. How B cells and T cells talk to each other. Nature 367:425.
8. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grosmaire, R. Stenkamp, M. Neubauer, R. L. Roberts, R. J. Noelle, J. A. Ledbetter, U. Francke, and H. S. Ochs. 1993. The CD40 ligand, gp 39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291.
9. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkens, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, W. C. Fanslow, J. Belmont, and M. K. Spriggs. 1993. CD40 ligand and gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.
10. Van Kooten, C., C. Gaillar, J.-P. Galizzi, P. Hermann, F. Fossiez, J. Banchereau, and D. Blanchard. 1994. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24:787.
11. Yellin, M. J., K. Sippel, G. Inghirami, L. R. Covey, J. J. Lee, J. Sinning, E. A. Clark, I. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40L: potential role in regulating helper effector function. J. Immunol. 152:598.
12. Baixeras, E., G. Kroemer, E. Cuendo, C. Marquez, L. Bosca, J. Martinez, and C. Martinez-A. 1993. Signal transduction pathways involved in B-cell induction. Immunol. Rev. 132:5.
13. Gold, M. R., and A. L. DeFranco. 1994. Biochemistry of B lymphocyte activation. Adv. Immunol. 55:221.
14. Chan, A. C., D. M. Desai, and A. Weiss. 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555.
15. Shaw, A. S., L. K. Timson-Gauen, and Y. Zhu. 1995. Interactions of TCR tyrosine based activation motifs with tyrosine kinases. Semin. Immunol. 7:13.
16. Varticovski, L., D. Harrison-Findik, M. L. Keeler, and M. Susa. 1994. Role of PI 3-kinase in mitogenesis. Biochim. Biophys. Acta 1226:1.
17. Kapeller, R., and L. C. Cantley. 1994. Phosphatidylinositol 3-kinase. BioEssays 16:565.
18. Divecha, N., and R. F. Irvine. 1995. Phospholipid signaling. Cell 80:269.
19. Fry, M. J., and M. D. Waterfield. 1993. Structure and function of phosphatidylinositol 3-kinase: a potential second messenger system involved in growth control. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 340:337.
20. Carpenter, C. L., and L. C. Cantley. 1990. Phosphoinositide kinases. Biochemistry 29:11147.
21. Dhand, R., I. Hiles, G. Panayotou, S. Roche, M. J. Fry, I. Gout, N. F. Totty, O. Truong, P. Vicendo, K. Yonezawa, M. Kasuga, S. A. Courtneidge, and M. D. Waterfield. 1994. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13:522.
22. Fantl, W. J., J. A. Escobedo, G. A. Martin, C. W. Turck, R. M. Del, F. McCormick, and L. T. Williams. 1992. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69:413.
23. Ling, L. E., B. J. Druker, L. C. Cantley, and T. M. Roberts. 1992. Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type level of PI 3-kinase products in intact cells. J. Virol. 66:1702.
24. Varticovski, L., G. Daley, P. Jackson, D. Baltimore, and L. Cantley. 1991. Activation of PI 3-kinase in cells expressing abl oncogene variants. Mol. Cell. Biol. 11:1107.
25. Valius, M., and A. Kazlauskas. 1993. Phospholipase C-γ1 and phosphatidylinositol 3-kinase are the downstream mediators of the PDGF receptors mitogenic signal. Cell 73:321.
26. Nakanishi, S., S. Kakita, I. Takahashi, K. Kawahara, E. Tsukuda, T. Sano, K. Yamada, M. Yoshida, H. Kase, Y. Matsuda, Y. Hashimoto, and Y. Nonomura. 1992. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267:2157.
27. Powis, G., R. Bonjouklian, M. M. Berggren, A. Gallegos, R. Abraham, C. Ashendel, L. Zalkow, W. F. Matter, J. Dodge, G. Gridey, and C. J. Vlahos. 1994. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54:2419.
28. Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846.
29. Okada, T., L. Sakuma, Y. Fukui, O. Hazeki, and M. Ui. 1994. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:3563.
30. Thelen, M., M. P. Wyman, and H. Langen. 1994. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc. Natl. Acad. Sci. USA 91:4960.
31. 2 activity in Swiss 3T3 cells. J. Biol. Chem. 270:25352.
32. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241.
33. Ueda, Y., B. L. Levine, M. L. Huang, G. J. Freeman, L. M. Nadler, C. H. June, and S. G. Ward. 1995. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int. Immunol. 7:957.
34. Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369:327.
35. Roche, S., M. Kogel, and S. A. Courtneidge. 1994. The phosphatidylinositol 3-kinase is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA 91:9185.
36. Prasad, K. V. S., Y.-C. Cai, M. Raab, B. Duckworth, L. Cantley, S. E. Shoelson, and C. E. Rudd. 1994. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 91:2834.
37. Ward, S. G., A. Wilson, L. Turner, J. Westwick, and D. M. Sansom. 1995. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur. J. Immunol. 25:526.
38. Turner, L., S. G. Ward, and J. Westwick. 1995. RANTES-activated human T lymphocytes: a role for phosphoinositide 3-kinase. J. Immunol. 155:2437.
39. Aagaard-Tillery, K. M., and D. F. Jelinek. 1996. Phosphatidylinositol 3-kinase activation in normal human B lymphocytes: differential sensitivity of growth and differentiation to wortmannin. J. Immunol. 156:4543.
40. Rosenberg, S. A., and P. E. Lipsky. 1979. Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin secreting cells from human peripheral blood mononuclear cells. J. Immunol. 122:926.
41. Thiele, D. L., and P. E. Lipsky. 1983. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in the human peripheral blood: delineation by its sensitivity to the lysosomotropic agent L-leucine methyl ester. J. Immunol. 131:2282.
42. Galili, U., and M. Schlesinger. 1974. The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J. Immunol. 112:1628.
43. Jelinek, D. F., and P. E. Lipsky. 1985. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells. J. Immunol. 134:1690.
44. Jelinek, D. F., J. B. Splawski, and P. E. Lipsky. 1986. Human peripheral blood B lymphocyte subpopulation: functional and phenotypic analysis of surface IgD positive and negative subsets. J. Immunol. 136:83.
45. Karnitz, L. M., L. A. Burns, S. L. Sutor, J. Blenis, and R. T. Abraham. 1995. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 15:3049.
46. Augustine, J. A., S. L. Sutor, and R. T. Abraham. 1991. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol. Cell Biol. 11:4431.
47. Cantrell, D. A., M. Izquierdo, K. Reif, and M. Woodrow. 1993. Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor. Semin. Immunol. 5:319.
48. Thompson, P. A., J. S. Gutkind, K. C. Robbins, J. A. Ledbetter, and J. B. Bolen. 1992. Identification of distinct populations of PI 3-kinase activity following T-cell activation. Oncogene 7:719.
49. Chirmule, N., T. W. McCloskey, R. Hu, V. S. Kalyanaraman, and S. Pahwa. 1995. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J. Immunol. 155:917.
50. Fuleihan, R., N. Ramesh, A. Homer, D. Ahern, P. J. Belshaw, D. G. Alberg, I. Stamenkovic, W. Harmon, and R. S. Geha. 1994. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 93:1315.
51. Klaus, S. J., L. M. Pinchuk, H. D. Ochs, C.-L. Law, W. C. Fanslow, R. J. Armitage, and E. A. Clark. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152:5643.
52. Nishioka, Y., and P. E. Lipsky. 1994. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol. 153:1027.
53. Tohma, S., S. Hirohata, and P. E. Lipsky. 1991. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation. J. Immunol. 146:492.
54. Ault, K. A. 1990. Application in immunology and lymphocyte analysis. In Flow Cytometry and Sorting. M. R. Melamed, T. Lindmo, and M. L. Mendelsohn, eds. Wiley-Liss, New York, p. 694.
55. Westendorf, J. J., J. M. Lammert, and D. F. Jelinek. 1995. Expression and function of Fas (AP)-1/CD95) in patient myeloma cells and myeloma cell lines. Blood 85:3566.
56. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induced expression of K7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
57. Cosulich, M. E., A. Risso, D. Smilovich, I. Baldissarro, M. C. Capra, and A. Bargellesi. 1992. CD69 activation molecule: requirements for ils expression on T cells. Pharmacol. Res. 26:136.
58. Ding, L., J. M. Green, C. B. Thompson, and E. M. Shevach. 1995. B7/CD28-dependent and -independent induction of CD40 ligand expression. J. Immunol. 155:5124.
59. June, C. H., J. A. Ledbetter, M. W. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
60. Castle, B. E., K. Kishimoto, C. Stearns, M. L. Brown, and M. R. Kehry. 1993. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151:1777.
61. Splawski, J. B., S. M. Fu, and P. E. Lipsky. 1993. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150:1276.
62. Lane, P., C. Burdet, F. McConnell, A. Lanzavecchia, and E. Padovan. 1995. CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol. 25:1788.
63. Farrington, M., L. S. Grosmaire, S. Nonoyama, S. Fischer, D. Hollenbaugh, J. A. Ledbetter, R. J. Noelle, A. Aruffo, and H. D. Ochs. 1994. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA 91:1099.
64. Foy, T., D. Sheperd, F. Durie, A. Aruffo, J. Ledbetter, and R. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged expression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.
65. Grabstein, K., C. R. Maliszewski, K. Shanebeck, T. A. Sato, M. K. Spriggs, W. C. Fanslow, and R. J. Armitage. 1993. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J. Immunol. 150:3141.